Letter to the Editor:We read with interest articles by Peters and Wentzell 1 and Benbenisty and colleagues 2 regarding Mohs micrographic surgery for cellular neurothekeomas. We, too, recently treated a patient with an atypical cellular neurothekeoma on the nose with Mohs surgery.A 19-year-old female presented to the office referred by dermatology for a red-brown papule on the left nasal tip that had been slowly growing over many months. Biopsy showed a cellular neurothekeoma with atypia and complete excision was recommended. Owing to the location and the tendency for recurrence, Mohs micrographic surgery was performed. The tumor was cleared in two stages. The resulting defect was repaired with a superiorly based island pedicle flap receiving its blood supply from a lateral nasalis muscle sling.The utility of Mohs surgery goes well beyond basal and squamous cell carcinomas and, in our opinion, beyond treatment of cutaneous malignancy. Behroozan and coworkers 3 described the application of Mohs surgery for benign skin tumors. Their point is certainly valid. Tissue-sparing surgery with margin control for benign lesions with a tendency for local recurrence is ideal. The basic tenets of Mohs surgery enable such tumor clearance unlike any other method.Third-party payers should be educated to realize the value of Mohs surgery and its place in treating certain benign skin lesions. They should provide coverage for removal of such benign skin tumors with tendency for local recurrence.
References1. Peters GE Jr, Wentzell M. Cellular neurothekeoma treated with Mohs micrographic surgery. Dermatol Surg 2007;33:239-44. 2. Benbenisty KM, Andea A, Metcalf J, et al. Atypical cellular neurothekeoma treated with Mohs micrographic surgery. Dermatol Surg 2006;32:582-7. 3. Behroozan DS, Goldberg LH, Glaich AS, et al. Mohs micrographic surgery for deeply penetrating, expanding benign cutaneous neoplasms. Dermatol Surg 2006;32:958-65.